Cupertino, CA, United States of America

Balu Palani

USPTO Granted Patents = 4 


Average Co-Inventor Count = 7.0

ph-index = 2

Forward Citations = 45(Granted Patents)


Company Filing History:


Years Active: 2006-2012

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations of Balu Palani in Erythropoietin Receptor Research

Introduction

Balu Palani is an accomplished inventor based in Cupertino, CA. He has made significant contributions to the field of biotechnology, particularly in the development of peptide compounds that target the erythropoietin receptor. With a total of four patents to his name, Palani's work has the potential to impact therapeutic methods for treating disorders related to red blood cell production.

Latest Patents

Palani's latest patents focus on peptide compounds that act as agonists of the erythropoietin receptor (EPO-R). These inventions describe therapeutic methods utilizing these peptide compounds to address conditions associated with insufficient or defective red blood cell production. Additionally, pharmaceutical compositions that incorporate these peptide compounds are also detailed in his patents.

Career Highlights

Balu Palani is currently associated with Affymax, Inc., where he continues to innovate in the field of peptide research. His work has garnered attention for its potential applications in treating various hematological disorders.

Collaborations

Palani collaborates with notable colleagues, including Christopher P. Holmes and Qun Yin, who contribute to the advancement of research in this area.

Conclusion

Balu Palani's innovative work in peptide compounds targeting the erythropoietin receptor showcases his commitment to advancing medical science. His contributions have the potential to lead to significant improvements in the treatment of blood-related disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…